At each event, two Principal Investigators (PIs) of MIBE will provide exciting insights into their research. After the talks, which take around 60 minutes, there is plenty of time for networking.
Prof. Dr. Alessandra Moretti: Human cardiac organoids: a new window into human heart development, disease, and regeneration
Prof. Dr. Julian Grünewald: Engineering CRISPR strategies for heart disease
Date and Time: Wednesday, June 14th, 2023, 4:15 pm – around 5:15 pm, afterwards networking
Place: MIBE lecture hall (room E.126), Boltzmannstraße 11, 85748 Garching and Zoom
At this point content of an external provider (source: www.youtube-nocookies.com) is integrated. When displaying, data may be transferred to third parties or cookies may be stored, therefore your consent is required.
You can find more information and the possibility to revoke your consent at our privacy statement.
At this point content of an external provider (source: www.youtube-nocookies.com) is integrated. When displaying, data may be transferred to third parties or cookies may be stored, therefore your consent is required.
You can find more information and the possibility to revoke your consent at our privacy statement.
Alessandra Moretti conducts research in the fields of stem cell biology and cardiac development. Her research focuses are 1) cardiovascular progenitors and their specification into the various heart cell lineages 2) cellular plasticity and 3) human induced pluripotent stem cells as model systems for studying cardiovascular disease and regeneration.
"A mini-heart in a Petri dish" - Press release (2023)
Image: Daniel Delang / TUM
Julian Grünewald studied medicine at the Universities of Freiburg, Salamanca and Paris. He received his doctorate in medicine from the University of Freiburg in 2015. Initially, he worked as a physician in internal medicine at the University Hospital of Freiburg. From 2017 to 2022, he conducted research as a postdoctoral fellow and instructor in pathology in the laboratory of Prof. J. Keith Joung at Massachusetts General Hospital and Harvard Medical School in Boston, USA. There he specialized in human cell gene editing with CRISPR technology. Since 2022, he has led an Emmy Noether Junior Research Group as a Rudolf Mößbauer Professor at TranslaTUM and in the Cardiology Department of TUM University Hospital Klinikum Rechts der Isar. He will also be active at the new TUM Center for Organoid Systems (COS) in Garching.
"Curing heart disease with CRISPR" - Press release (2023)
Image: Andreas Heddergott / TUM
Further Information
Livestream
There will be a live-stream for this event via zoom.
Zoom details: We are MIBE Speaker Series, https://tum-conf.zoom.us/j/612 2888 8412, Meeting-ID: 612 2888 8412 Passcode: waMIBE
Recognition Qualification Program for Doctoral Candidates
If you're doing your doctorate within the field of biomedical engineering, regular participation in the speaker series can be counted towards subject-specific qualification in DocGS.
Registration form for doctoral candidates